Biotricity (NASDAQ:BTCY) Trading 6.9% Higher – Time to Buy?

On January 3rd, 2025, Biotricity, Inc. (NASDAQ:BTCY) saw its stock rise by 6.9% during mid-day trading. The stock reached a peak price of $0.33 before settling at $0.31. During this trading session, approximately 104,856 shares changed hands, which is a significant increase of 37% compared to the average daily volume of 76,434 shares. The previous closing price for Biotricity was $0.29.

Wall Street Analysts Forecast Growth

In a fresh assessment, HC Wainwright maintained a “neutral” rating for Biotricity’s shares in a research report published on November 18th. This perspective comes amidst the recent performance fluctuations of the stock.

Biotricity Stock Up 6.9%

Currently, Biotricity's stock operates with a 50-day moving average price of $0.32 and a 200-day moving average price of $0.46. The company holds a market capitalization of $7.61 million, a price-to-earnings (P/E) ratio of -0.23, and a beta value of 1.14, indicating relative volatility in comparison to the broader market.

Institutional Inflows and Outflows

Recently, an institutional investor made a noteworthy addition to Biotricity's stock. AE Wealth Management LLC established a new position in Biotricity during the second quarter, as outlined in their latest filing with the Securities and Exchange Commission. They acquired 97,751 shares of the company, amounting to an investment of approximately $88,000. By the end of the latest quarter, AE Wealth Management LLC held a 0.45% stake in Biotricity. The total institutional ownership in Biotricity stands at about 3.89%.

About Biotricity

Biotricity, Inc. is a medical technology firm focused on delivering biometric data monitoring solutions across the United States. The company specializes in remote monitoring solutions tailored for medical, healthcare, and consumer markets, including both diagnostic and post-diagnostic strategies for managing lifestyle and chronic illnesses.

Conclusion

Given the recent rise in stock price and the ongoing interest from institutional investors, it might be worth considering whether now is the right time to invest in Biotricity.

Biotricity, investment, market, trading, stocks